← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

American Financial Group, Inc. (AFG) 10-Year Financial Performance & Capital Metrics

AFG • • Insurance & Managed Care
Financial ServicesProperty & Casualty InsuranceCommercial Lines InsuranceDiversified Commercial Lines
AboutAmerican Financial Group, Inc., an insurance holding company, provides specialty property and casualty insurance products in the United States. It offers property and transportation insurance products, such as physical damage and liability coverage for buses and trucks, inland and ocean marine, agricultural-related products, and other commercial property and specialty transportation coverages; specialty casualty insurance, including primarily excess and surplus, executive and professional liability, general liability, umbrella and excess liability, and specialty coverage in targeted markets, as well as customized programs for small to mid-sized businesses and workers' compensation insurance; and specialty financial insurance products comprising risk management insurance programs for lending and leasing institutions, fidelity and surety products, and trade credit insurance. The company sells its property and casualty insurance products through independent insurance agents and brokers. American Financial Group, Inc. was founded in 1872 and is headquartered in Cincinnati, Ohio.Show more
  • Revenue $8.28B +7.1%
  • Combined Ratio 86.42% +0.4%
  • Net Income $887M +4.1%
  • Return on Equity 20.33% -0.8%
  • Medical Cost Ratio 82.21% -0.3%
  • Operating Margin 13.58% -2.2%
  • Net Margin 10.72% -2.8%
  • ROA 2.93% +0.7%
  • Equity / Assets 14.48% +1.3%
  • Book Value per Share 53.23 +6.0%
  • Tangible BV/Share 47.18 +1.2%
  • Debt/Equity 0.33 -4.7%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Profitable underwriting: 86.4% combined ratio
  • ✓Excellent 3Y average ROE of 20.2%
  • ✓Strong Piotroski F-Score: 9/9

✗Weaknesses

  • ✗High loss ratio of 82.2%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y3.74%
5Y6.24%
3Y9.93%
TTM0.11%

Profit (Net Income) CAGR

10Y6.97%
5Y-0.22%
3Y-23.68%
TTM-10.84%

EPS CAGR

10Y7.84%
5Y1.4%
3Y-23.16%
TTM-10.67%

ROCE

10Y Avg6.06%
5Y Avg2.93%
3Y Avg3.85%
Latest3.86%

Peer Comparison

Diversified Commercial Lines
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
SIGISelective Insurance Group, Inc.5.01B82.9725.6914.87%7.78%11.65%21.33%0.16
LLoews Corporation21.32B103.1616.099.96%8.07%7.55%11.22%0.50
WRBW. R. Berkley Corporation26.11B68.7115.7612.32%13.01%19.44%13.68%0.34
THGThe Hanover Insurance Group, Inc.6.05B170.1514.544.25%9.75%18.44%13.15%0.28
CBChubb Limited118.5B301.1113.2612%16.48%12.43%13.66%0.22
CNACNA Financial Corporation12.56B46.4213.196.66%6.84%8.81%19.71%0.28
TRVThe Travelers Companies, Inc.60.53B271.3412.6412.22%12.13%18.58%14.99%0.29
AFGAmerican Financial Group, Inc.11B131.9012.487.12%9.7%16.87%10.47%0.33

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+6.14B6.5B6.87B6.99B6.12B5.67B6.23B6.77B7.73B8.28B
Revenue Growth %0.07%0.06%0.06%0.02%-0.12%-0.07%0.1%0.09%0.14%0.07%
Medical Costs & Claims+5.17B5.28B5.63B6.06B5.49B5.37B4.86B5.58B6.37B6.8B
Medical Cost Ratio %----------
Gross Profit+976M1.22B1.23B933M628M301M1.37B1.2B1.35B1.47B
Gross Margin %----------
Gross Profit Growth %-0%0.25%0.01%-0.24%-0.33%-0.52%3.56%-0.13%0.13%0.09%
Operating Expenses+411M430M507M294M-6M-38M37M73M282M349M
OpEx / Revenue %----------
Depreciation & Amortization134M134M107M210M259M299M187M100M78M81M
Combined Ratio %----------
Operating Income+565M787M724M639M634M339M1.33B1.12B1.07B1.12B
Operating Margin %----------
Operating Income Growth %-0.1%0.39%-0.08%-0.12%-0.01%-0.47%2.94%-0.16%-0.04%0.05%
EBITDA+699M921M831M849M893M638M1.52B1.22B1.15B1.21B
EBITDA Margin %----------
Interest Expense75M77M85M62M68M88M94M85M76M76M
Non-Operating Income-75M-77M-85M-62M-68M-88M-94M-85M-76M-76M
Pretax Income+565M787M724M639M634M339M1.33B1.12B1.07B1.12B
Pretax Margin %----------
Income Tax+195M119M247M122M143M25M254M225M221M237M
Effective Tax Rate %----------
Net Income+352M649M475M530M897M732M2B898M852M887M
Net Margin %----------
Net Income Growth %-0.22%0.84%-0.27%0.12%0.69%-0.18%1.73%-0.55%-0.05%0.04%
EPS (Diluted)+3.947.335.285.859.868.2123.3010.5310.0510.57
EPS Growth %-0.21%0.86%-0.28%0.11%0.69%-0.17%1.84%-0.55%-0.05%0.05%
EPS (Basic)4.027.475.385.969.988.2523.4910.5510.0610.57
Diluted Shares Outstanding89.4M88.5M89.8M90.6M91M89.2M85.6M85.3M84.8M83.9M

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+49.86B55.07B60.66B63.46B70.13B73.71B28.94B28.83B29.79B30.84B
Asset Growth %0.05%0.1%0.1%0.05%0.11%0.05%-0.61%-0%0.03%0.04%
Total Investment Assets+36.52B39.33B43.71B46.98B96.75B11.83B23.3B22.93B14.04B2.28B
Long-Term Investments34.26B36.46B40.39B45.29B50.24B11.23B12.94B12.84B13.27B1.74B
Short-Term Investments32.28B36.05B38.38B42B46.51B9.08B10.36B10.1B10.38B540M
Total Current Assets+2.32B3.16B3.55B44.75B54.54B018.13B14.63B010.79B
Cash & Equivalents1.22B2.11B2.34B1.51B2.31B1.67B2.13B872M1.23B1.41B
Receivables0001000K1000K1000K1000K1000K1000K1000K
Other Current Assets0005.16B5.74B-16.71B4.66B-3.46B-19.68B0
Goodwill & Intangibles+240M233M225M261M250M176M352M354M305M508M
Goodwill199M199M199M207M207M176M246M246M305M305M
Intangible Assets41M34M26M54M43M0106M108M0203M
PP&E (Net)-886M-1.05B-853M-872M158M0118M103M0212M
Other Assets13.08B15.25B16.52B-26.79B-1.21B-11.41B-619M-594M-13.57B17.59B
Total Liabilities45.09B50.15B55.32B58.48B63.86B66.92B23.93B24.78B25.53B26.37B
Total Debt+1.02B1.28B1.3B1.3B1.47B1.96B1.96B1.61B1.48B1.48B
Net Debt-200M-824M-1.04B-213M-841M298M-167M624M250M69M
Long-Term Debt998M1.28B1.3B1.3B1.47B1.96B1.96B1.5B1.48B1.48B
Short-Term Debt00000038M36M00
Total Current Liabilities+44.25B48.87B54.03B57.18B814M0920M1.03B01.19B
Accounts Payable2.79B2.94B3.7B3.69B3.84B3.92B4.34B1.03B1.19B1.19B
Deferred Revenue0000768M0882M000
Other Current Liabilities-2.79B-2.94B-3.7B-3.69B-3.79B-3.92B-4.34B-36M-1.19B0
Deferred Taxes1000K1000K1000K1000K1000K01000K1000K00
Other Liabilities35.53B0000-1.96B-1.96B2.73B-1.48B23.7B
Total Equity+4.77B4.92B5.33B4.97B6.27B6.79B5.01B4.05B4.26B4.47B
Equity Growth %-0.06%0.03%0.08%-0.07%0.26%0.08%-0.26%-0.19%0.05%0.05%
Shareholders Equity4.59B4.92B5.33B4.97B6.27B6.79B5.01B4.05B4.26B4.47B
Minority Interest178M3M4M2M000000
Retained Earnings2.99B3.34B3.25B3.59B4.01B4.15B3.48B3.14B3.12B3.21B
Common Stock87M87M88M89M90M86M85M85M84M84M
Accumulated OCI304M375M813M48M863M1.27B119M-543M-319M-240M
Return on Equity (ROE)0.07%0.13%0.09%0.1%0.16%0.11%0.34%0.2%0.21%0.2%
Return on Assets (ROA)0.01%0.01%0.01%0.01%0.01%0.01%0.04%0.03%0.03%0.03%
Equity / Assets----------
Debt / Equity0.21x0.26x0.24x0.26x0.23x0.29x0.39x0.40x0.35x0.33x
Book Value per Share53.3655.5859.4054.8868.8976.1158.5547.5050.2153.23
Tangible BV per Share----------

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+1.36B1.15B1.8B2.08B2.46B2.18B1.71B1.15B1.97B1.15B
Operating CF Growth %0.1%-0.15%0.57%0.15%0.18%-0.11%-0.21%-0.33%0.71%-0.42%
Operating CF / Revenue %----------
Net Income352M649M477M530M869M721M2B898M852M887M
Depreciation & Amortization132M134M107M210M259M299M187M100M78M81M
Stock-Based Compensation27M28M30M23M23M20M16M19M00
Deferred Taxes0000-23M-20M-16M-19M00
Other Non-Cash Items648M559M668M993M542M779M-1.27B-31M7M-54M
Working Capital Changes196M-220M522M327M786M384M805M186M1.03B238M
Cash from Investing+-4.58B-2.98B-3.29B-5.35B-3.06B-1.56B-436M-1.05B414M95M
Capital Expenditures67M-49M-109M-43M-44M-343M-150M-86M0-133M
Acquisitions-42M-364M-205M-23M4M-425M1.4B-10M-205M-9M
Purchase of Investments-9.3B-10.74B-2.98B-13.84B-10.89B-13.14B-10.72B-6.28B-2.3B-4.64B
Sale/Maturity of Investments1000K1000K01000K1000K1000K1000K1000K1000K1000K
Other Investing-174M-5M1M30M-261M-1M32M-128M718M25M
Cash from Financing+3.1B2.72B1.72B2.44B1.41B-123M-1.96B-1.36B-2.03B-1.07B
Dividends Paid-176M-185M-417M-394M-444M-334M-2.37B-1.21B-684M-788M
Share Repurchases-126M-133M0-6M0-313M-319M-11M-213M0
Stock Issued61M35M37M33M36M22M66M16M15M17M
Debt Issuance (Net)-1000K1000K-1000K01000K1000K0-1000K-1000K0
Other Financing3.38B2.72B2.13B2.81B1.65B18M670M324M-1.13B-295M
Net Change in Cash+-123M887M231M-823M799M496M-679M-1.26B353M181M
Exchange Rate Effect0000000000
Cash at Beginning1.34B1.22B2.11B2.34B1.51B2.31B2.81B2.13B872M1.23B
Cash at End1.22B2.11B2.34B1.51B2.31B2.81B2.13B872M1.23B1.41B
Free Cash Flow+1.42B1.1B1.7B2.04B2.41B1.84B1.56B1.07B1.9B1.15B
FCF Growth %0.67%-0.23%0.54%0.2%0.18%-0.24%-0.15%-0.32%0.78%-0.39%
FCF Margin %----------
FCF per Share15.9312.4418.8822.5226.5120.6318.2712.5122.3813.73

Key Ratios

Metric2015201620172018201920202021202220232024
Combined Ratio90.81%87.89%89.45%90.86%89.63%94.02%78.57%83.42%86.12%86.42%
Medical Cost Ratio84.12%81.27%82.07%86.65%89.73%94.69%77.98%82.34%82.47%82.21%
Return on Equity (ROE)7.17%13.4%9.27%10.29%15.96%11.21%33.81%19.81%20.51%20.33%
Return on Assets (ROA)0.72%1.24%0.82%0.85%1.34%1.02%3.89%3.11%2.91%2.93%
Equity / Assets9.57%8.93%8.79%7.84%8.94%9.21%17.32%14.05%14.29%14.48%
Book Value / Share53.3655.5859.454.8868.8976.1158.5547.550.2153.23
Debt / Equity0.21x0.26x0.24x0.26x0.23x0.29x0.39x0.40x0.35x0.33x
Revenue Growth7.19%5.74%5.65%1.81%-12.49%-7.29%9.89%8.7%14.1%7.12%

Revenue by Segment

2015201620172018201920202021202220232024
Property and Casualty Insurance4.22B4.33B4.58B4.87B5.18B5.1B5.4B6.08B7.28B7.83B
Property and Casualty Insurance Growth-2.46%5.80%6.25%6.58%-1.66%5.98%12.60%19.57%7.59%
Corporate and Other194M240M283M24M22M19M293M376M591M496M
Corporate and Other Growth-23.71%17.92%-91.52%-8.33%-13.64%1442.11%28.33%57.18%-16.07%
Annuity1.32B1.46B1.56B1.75B1.9B1.83B----
Annuity Growth-10.36%6.99%11.79%8.88%-3.68%----
Run-off Long-term Care and Life104M24M22M-------
Run-off Long-term Care and Life Growth--76.92%-8.33%-------

Frequently Asked Questions

Valuation & Price

American Financial Group, Inc. (AFG) has a price-to-earnings (P/E) ratio of 12.5x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

American Financial Group, Inc. (AFG) grew revenue by 7.1% over the past year. This is steady growth.

Yes, American Financial Group, Inc. (AFG) is profitable, generating $798.0M in net income for fiscal year 2024 (10.7% net margin).

Dividend & Returns

Yes, American Financial Group, Inc. (AFG) pays a dividend with a yield of 7.12%. This makes it attractive for income-focused investors.

American Financial Group, Inc. (AFG) has a return on equity (ROE) of 20.3%. This is excellent, indicating efficient use of shareholder capital.

Industry Metrics

American Financial Group, Inc. (AFG) has a combined ratio of 86.4%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.